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The health of infants, children, and the com-
munity can be improved by increasing
breast-feeding rates and by decreasing com-
munity “body burdens” (chemical levels in
humans). These objectives can be addressed
by a program that monitors body burdens
using breast milk. Currently, the United
States has no body-burden monitoring pro-
gram using breast milk, although ad hoc sys-
tems operate successfully in several European
countries. In this article we describe the value
of such monitoring and some important con-
siderations of how this might be accom-
plished, drawing from our experiences with
pilot monitoring projects in Kazakhstan and
in Stockton, CA. We argue that breast milk
is effective in expanding primary prevention
(reducing chemical exposures that harm the
fetus, newborn, and child), in no small part
because ﬁnding industrial chemicals in breast
milk has stimulated public response and reg-
ulatory action.
Lessons of the Polybrominated
Diphenyl Ethers
Swedish body burden monitoring studies (1,2)
for polybrominated diphenyl ethers (PBDEs)
make clear that breast milk is a highly visible
and socially important sampling matrix.
PBDEs have been in use for the past 25 years as
ﬂame retardants; as such, they are major, non-
chemically bound additives to fabrics, foams,
and plastics, comprising up to 30% by weight
of polyurethane foams and computer plastics
(3–5). Until recently, PBDEs were considered
obscure members of the persistent organic pol-
lutants (POPs) family, whose other members
include polychlorinated biphenyls (PCBs),
polychlorinated dibenzodioxins and -furans
(PCDDs/PCDFs), and organochlorine pesti-
cides (3,6,7). In 1992, exponential increases
in PBDEs were found in marine sediment
core samples taken from the Swedish coast
over a 10-year period (7,8), but the study
attracted little attention. Not until similar
exponential increases were found in archived
samples of Swedish breast milk in 1998 did
the presence of PBDEs become known in
Sweden and receive worldwide scientiﬁc and
public attention: PBDE levels in breast milk
had been doubling every 5 years over the pre-
ceding 25 years, but no one had known about
it (Figure 1) (1,2,8). 
At the time of the Swedish study (1), few
measurements of PBDEs had been made in
the United States in either biota or humans.
Indeed, no comparable time-trend data exist
to this day. Two recent studies (9,10) from
our laboratory indicated the need for more
body burden monitoring in the United States
and the value of using breast milk. One study
reported that women in the San Francisco
Bay, California, region had the highest PBDE
body burdens in the world, 6- to 10-fold
higher than levels reported for Europeans
(Figure 2A) (9). Results from a second study
showed that PBDE levels in San Francisco
Bay harbor seals had been doubling every two
years and had increased 100-fold over the
past decade (Figure 2B) (10). Both studies
used samples of adipose tissue rather than
breast milk. In contrast to the Swedish breast
milk study, both generated limited public and
regulatory response. Comparing responses
from the Swedish and U.S. public has its lim-
itations, but it seems fair to say from these
time-trend studies that “When breast milk
speaks, people listen!” Signiﬁcantly, the pres-
ence of strontium 90 in breast milk and
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Levels of chemicals in humans (body burdens) are useful indicators of environmental quality and
of community health. Chemical body burdens are easily monitored using breast milk samples col-
lected from ﬁrst-time mothers (primiparae) with infants 2–8 weeks of age. Currently, there is no
body-burden monitoring program using breast milk in the United States, although ad hoc systems
operate successfully in several European countries. In this article we describe the value of such
monitoring and important considerations of how it might be accomplished, drawing from our
experiences with pilot monitoring projects. Breast milk has several advantages as a sampling
matrix: It is simple and noninvasive, with samples collected by the mother. It monitors body bur-
dens in reproductive-age women and it estimates in utero and nursing-infant exposures, all impor-
tant to community health. Time-trend data from breast milk monitoring serve as a warning
system that identiﬁes chemicals whose body burdens and human exposures are increasing. Time
trends also serve as a report card on how well past regulatory actions have reduced environmental
chemical exposures. Body-burden monitoring using breast milk should include educational pro-
grams that encourage breast-feeding. Finally, and most important, clean breast milk matters to
people and leads to primary prevention—the limiting of chemical exposures. We illustrate these
advantages with polybrominated diphenyl ethers (PBDEs), a formerly obscure group of bromi-
nated ﬂame retardants that rose to prominence and were regulated in Sweden when residue levels
were found to be rapidly increasing in breast milk. A community-based body-burden monitoring
program using breast milk could be set up in the United States in collaboration with the Special
Supplemental Nutrition Program for Women, Infants, and Children (WIC). WIC has a large
number of lactating first-time mothers: It has 6,000 clinics nationwide and serves almost half
(47%) the infants born in the United States. Educational programs (e.g., those run by WIC) are
needed that encourage breast-feeding, especially in lower-income communities where breast-feed-
ing rates are low and where breast-feeding may help protect the infant from the effects of environ-
mental chemical exposures. Education is also needed about reducing chemical body burdens. A
body-burden monitoring program would provide valuable data on time trends, background levels,
and community hot spots in need of mitigation and follow-up health studies; develop analytic
methods for new chemicals of concern; and archive breast milk samples for future analyses of
other agents. Key words: body burdens, breast milk, breast-feeding, environmental justice, hot
spots, human monitoring, Kazakhstan, persistent organic pollutants, polybrominated diphenyl
ethers, precautionary principle, primary prevention, WIC clinics. Environ Health Perspect
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[Online 11 December 2002]other foods in the United States was a major
contributor to the ban on atmospheric
nuclear testing (11).
Several lessons can be learned from the
Swedish breast milk study. Most important is
that breast milk occupies a special place in the
public mind: People seem unconsciously to
invoke the precautionary principle more read-
ily for chemicals in breast milk than for those
in blood, urine, or fat. Because breast milk
speaks loudly, catching the public’s attention,
body burden data from breast milk can serve
as an effective warning system for new chemi-
cals in need of regulatory attention (e.g.,
PBDEs) (12). Time-trend data serve as a
report card on the effectiveness of past regula-
tory strategies to lower community body bur-
dens. These data tell us that regulation works:
Body burdens of PCBs and polychlorinated
dioxins/furans in the Swedish breast milk
study decreased 50% in the 20-year period
(1972–1992) following regulation (Figure 1)
(1). Time trends showed further that the
Swedish responses to PBDEs were effective:
PBDE body burdens began to trend down-
ward following the phaseout of the penta-
PBDE flame retardant in the late 1990s
(Figure 1) (2).
Advantages of Body-Burden
Monitoring
Primary prevention seeks to reduce the pub-
lic’s exposures to toxic chemicals. A monitor-
ing system can help with primary prevention
if we initiate mitigation measures when
increases in specific chemicals are found.
Different chemicals require different systems.
Many industrial organic chemicals are
volatile, water-soluble, or rapidly transformed
(environmentally degraded or metabolized by
biota), and reside only briefly in biota or
humans. Because body burdens are transient,
it makes sense to monitor these chemicals by
monitoring levels in matrices (e.g., urban air
or water) that are signiﬁcant sources of shared
exposures for major populations. 
In contrast, other chemicals (e.g., POPs)
are relatively nonvolatile or sparingly soluble
in water, and neither air nor water is the
major source of human exposure. POPs are
lipophilic and stable; they bioaccumulate in
the fat of biota and humans and biomagnify
up the food chain. Humans are near the top
of this ecologic food pyramid, with breast-fed
infants at the very peak. POP chemicals need
to be monitored because several adverse
health effects in humans have been linked to
POP exposures, including cancer (13,14) and
altered infant sex ratio (15,16) with 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD), neu-
rodevelopmental cognitive-motor deficits
with PCBs (17–20), and shortened duration
of lactation with o,p-DDE (21). POPs are
suspected of acting as pseudo-hormones [e.g.,
as estrogens, anti-estrogens, or, with PBDEs,
as thyroid hormone mimics (6)] by a variety
of mechanisms, including interfering with
hormone synthesis or metabolism, carrier
protein concentrations, carrier protein func-
tion, and transcriptional activation. If so,
even trace levels of POPs may produce signif-
icant biologic effects.
Although dietary animal fat is the major
source for many POPs, nondietary sources
may be significant for others (e.g., PBDEs).
For example, polyurethane foam, as found in
sofas, contains penta-PBDEs up to ~30% by
weight (5,22). The foam crumbles at the sur-
face and disperses into dust after 4 weeks of
sun exposure at ambient summer conditions
(5,22), and the nonchemically bound PBDEs
may leach or volatilize from the dust particles.
Variable diets within a population hamper
our ability to predict POP body burdens
from residue levels measured in foods.
Monitoring POPs in environmental sentinel
biota (e.g., fish, shellfish, raptor birds) can
alert us to new chemicals, but dietary differ-
ences between biota and humans again limit
the predictive value of these data for levels or
time trends in humans.
For POPs, direct measurement of body
burdens seems the best means of tracking
human exposures. Such measurements are, in
fact, multimedia monitoring, as they inte-
grate exposures from all sources and path-
ways. Optimally, a human body burden
monitoring program would accomplish five
objectives: establish background levels; iden-
tify chemicals or regions in need of mitigation
or follow-up health studies (hot spots); exam-
ine changes of body burdens over time (time
trends); develop analytic methods for new
persistent chemicals of interest; and systemat-
ically archive samples for future studies of
new chemicals of concern.
Regarding the second objective, identify-
ing problem chemicals, given the difficulties
and complexities of health studies, the lessons
learned from DDT and the PCBs should
encourage us to take precautionary action
(mitigation) to reduce levels of POPs with
toxic effects when we ﬁnd their levels increas-
ing in breast milk. PBDEs, like PCBs before
them, fulﬁll the three elements of the precau-
tionary principle: plausibility of harm, scien-
tiﬁc uncertainty that is difﬁcult to resolve, and
the beneﬁts of precautionary action (23,24). 
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Figure 1. Organohalogen compounds in breast milk in Sweden. Data from Norén and Mieronyté (1) and
Guvenius and Norén (2). 
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Figure 2. High and increasing levels of PBDEs in California. (A) PBDE levels in humans’ regional compar-
isons. (B) Persistent organic pollutants in harbor seals from San Francisco Bay. 
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Sweden (milk)Advantages of Community-
Based Monitoring
Communities are centers of social, cultural,
and political activity and thus are the logical
places within which body burden monitoring
and breast-feeding education can be linked.
Communities have the energy and political
will as well as the responsibility to transform
the ﬁnding of elevated community body bur-
dens into demands for mitigation and/or reg-
ulation to limit exposures. 
As with other public health interventions
(e.g., clean water and proper sanitation to pre-
vent infectious diseases), primary prevention
for environmental health occurs collectively at
the community, state, and/or national levels,
not at the individual level. Preventive mea-
sures are introduced that lead to cleaner air,
water, food, and the like and that limit the
public’s exposure to noxious factors.
An effective monitoring program would
identify communities with significant expo-
sures and query highly exposed individuals to
identify potential major sources/pathways of
human exposure. Time-trend data would
assess the effectiveness of mitigation strate-
gies. Some of our monitoring efforts, there-
fore, should focus on potential hot spots (e.g.,
underserved or under-resourced populations
living in heavily industrialized areas at-risk for
environmental chemical exposures). A num-
ber of low-income communities concerned
about environmental justice have stepped for-
ward and asked that their community body
burdens be characterized (25). 
Advantages of Individual ver-
sus Pooled Data
In all but the most extreme cases, physicians
cannot predict the health consequences of an
individual’s POPs body burden, nor can they
offer a means of lowering this burden. Thus,
from a treatment standpoint, POP residue data
are of limited use to the individual. From a
public health standpoint, however, individual
data are extremely useful to the community
because they give us ranges and distributions of
POP body burdens not provided by pooled
samples. However, to prevent potential adverse
social or economic consequences, data from
individuals must be kept strictly conﬁdential. 
Advantages of Exposure
Registry
One solution is to report publicly only com-
munity-wide summary data with ranges and
distributions and to maintain confidential
individual data in a registry. This protocol pro-
tects the individual, emphasizes the commu-
nity basis of the monitoring, and focuses
responsibility for action on the community.
In a manner similar to cancer or birth
defects registries, exposure registries of body
burden data would characterize spatial (hot
spots) and temporal (time trends) patterns as
well as normative backgrounds, except that
body burden data, not diagnoses of disease or
defects, are recorded. Just as data from health
registries have been used to intervene and pre-
vent morbidity, data from a body burden reg-
istry can be used to develop rational strategies
to lower (prevent, mitigate, or remediate)
chemical exposures.
Advantages of Breast Milk
Three tissue options—adipose, blood, or
breast milk—are available to monitor for
trace POPs body burdens, and all require
chemically clean collection procedures.
Adipose tissue is poorly suited for routine
monitoring because sample collection
requires surgical intervention.
The signiﬁcant advantage of blood is that
diverse populations can be sampled—male,
female, young, and old. However, blood has
several disadvantages: Samples must be col-
lected under chemically clean and strictly
sterile conditions to minimize the risk of
transmission of infectious disease among sam-
ple donors, collectors, and lab analytic
personnel. A phlebotomist is required, prefer-
ably in a hospital or clinic setting, and correct
disposal of blood-contaminated materials
(e.g., needles, bandages, vacutainers, tops) is
necessary. Serum samples must be prepared
onsite, requiring clinical centrifuges and
equipment to transfer serum from vacutainers
to chemically clean jars. Because the fat con-
tent of blood (0.3–0.5%) is one-tenth that of
milk (3–5%), the volume of blood required
for chemical analysis is 10 times greater than
the volume of breast milk.
In contrast, breast milk is a convenient
and noninvasive alternative matrix for measur-
ing body burdens of POPs. Donors are
selected according to the World Health
Organization (WHO) criteria, namely healthy
first-time mothers (primiparae) with healthy
infants 2–8 weeks of age (26). These criteria
standardize the interindividual measurement
of body burdens by limiting donors to moth-
ers with no prior breast-feeding episodes
(which lower body burdens) and by collecting
samples early in lactation (which limits the
length of lactation before sampling). Samples
are easily collected: First-time mothers hand-
express milk into chemically clean jars and
refrigerate, as if collecting and storing milk for
their infant. Collection occurs in the mother’s
home and at her own pace. An obvious draw-
back is that only lactating women can be sam-
pled, which decreases the diversity of the
sampled population. However, body burdens
in young lactating women should reasonably
approximate community body burdens of
similarly young men and women arising from
environmental chemical exposures. Moreover,
breast milk is ideally suited for monitoring
POP body burdens in reproductive-age
women, and in estimating body burdens for
subpopulations whose health is critical to the
future economic well-being of the commu-
nity, and from whom blood samples are difﬁ-
cult to obtain: namely, the fetus and the
breast-fed infant or young child. A difﬁculty
with breast milk is that a potential donor
needs to be contacted during pregnancy to
determine whether she wishes to participate,
and samples are collected 2–8 weeks after
birth to adhere to the WHO protocol. 
Advantages of Women,
Infants, and Children Clinics
The Special Supplemental Nutrition Program
for Women, Infants, and Children (WIC)
Clinics provides access to a signiﬁcant cross-sec-
tion of pregnant, soon-to-be lactating, ﬁrst-time
mothers from lower-income, at-risk populations
in the United States. WIC has 6,000 clinics
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Figure 3. U.S. breast-feeding rates and WIC participants. 
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Total participationnationwide and serves 7 million persons (preg-
nant or postpartum women, infants, and chil-
dren up to age 5) in families that meet the
low-income eligibility guidelines (27).
Currently, 62% of infants born in California
and 47% of all babies born in the United States
are served by the WIC clinics (27,28).
Value of Breast-Feeding
Education
For some POP chemicals (e.g., PCBs), breast-
fed infants take in much greater (50-fold
higher) amounts than adults on a body
weight basis (29–31). This poses a dilemma
for new mothers and public health officials.
Should we limit breast-feeding?
First, the health beneﬁts for the breast-fed
infant are well documented and include
decreased rates of diarrhea and of respiratory,
ear, and urinary tract infections as well as
increased immune surveillance (32). Second,
the health problems documented in infants
from POP chemical exposures (e.g., neurode-
velomental deﬁcits, altered sex ratio) seem to
be caused not by chemicals in breast milk (lac-
tational exposures) but by in utero exposures
or paternal factors—that is, by the chemical
body burdens of the mother and father, or the
community’s body burden (15,16,19). The
female-biased infant sex ratio reported from
TCDD exposures in Seveso is linked to the
TCDD body burden of the father, not the
mother nor to lactational exposures (15,16).
The neurodevelopmental deﬁcits seen in off-
spring whose mothers are in the highest 10th
percentile of “background” PCB levels appear
to arise from in utero rather than lactational
exposures, as the most severe deﬁcits are seen
in nonbreast-fed infants (19,20).
Finally, one study (33,34) suggests that
chemicals in breast milk should encourage
rather than discourage breast-feeding. Breast
milk appears to reduce the severity of the
effects on the infant from the mother’s body
burdens and, to some extent, rescue the
infant from these effects. In the PCB–neu-
rodevelopmental study, infants and children
who were breast-fed outperformed bottle-fed
offspring on the neurodevelopmental tests,
suggesting that breast-feeding decreased the
health risks stemming from in utero PCB
exposures (33,34). Breast milk is known to
contain factors that stimulate the develop-
ment of the immune system and brain in the
infant (32), and it may also have evolved fac-
tors that help ameliorate fetal damage caused
by in utero exposures. Because we are descen-
dants of herbivorous primates with a long his-
tory of ingestion of plant defense substances,
in utero damage likely has a long history as
well and did not begin with exposures to
modern xenobiotics. An evolutionary advan-
tage would be gained by those primates
whose breast milk conferred to the infant the
gift of restoration as well as the wealth of
other beneﬁts. Several studies have indicated
that breast-fed daughters have a 25% lower
breast cancer incidence than nonbreast-fed
daughters (35,36), consistent with breast
milk reversing in utero damage.
Counterintuitive as it sounds, it may be
that the higher the mother’s chemical body
burden, within limits, the greater are the
health beneﬁts conveyed to her infant by her
breast milk and the more important it is for
her to breast-feed, to help reverse any transpa-
ternal damage to the fetus. It may be that
xenobiotics in breast milk are not particularly
harmful. It may be that these contaminants
cause signiﬁcant harm only when they reside
in the community, sequestered in the mother
and father before conception, to later affect
the health of the developing fetus.
An oft-cited disadvantage of using breast
milk to monitor body burdens is that infor-
mation on contaminants in breast milk dis-
courages mothers from breast-feeding. It is
not clear, however, that breast-feeding rates
are lower in the United States than in other
industrialized nations because of fear of conta-
minants, nor is it clear that talk of contami-
nants discourages breast-feeding. In southern
Kazakhstan, mothers are aware of environ-
mental contamination, but breast-feeding is
nearly universal (37–39). Likewise, in Sweden
and Norway, awareness of contaminants is
high, but breast-feeding rates are higher than
in the United States (80–90% vs. 65–70%)
(40). It is, however, clear that any body-bur-
den monitoring using breast milk should be
accompanied by breast-feeding education pro-
grams that describe the advantages of breast
milk, the disadvantages of infant formula, and
the importance of breast-feeding for commu-
nities with higher body burdens. 
Thus, an added benefit of monitoring
body burdens through breast milk is that edu-
cational components can encourage and sup-
port the practice of breast-feeding and stress
the importance of lowering chemical body
burdens. The community learns that environ-
mental chemicals are in everyone, not just the
lactating mother and that reducing chemical
body burdens is everyone’s responsibility.
They learn that a mother can reﬂect the com-
munity’s body burden of environmental
chemicals by donating a sample of breast milk
early in her ﬁrst lactation. And they learn that
scientiﬁc evidence suggests that breast-feeding
is even more important in communities with
higher chemical body burdens.
WIC runs educational programs that have
increased breast-feeding rates in lower-income
populations. Breast-feeding was universal in the
United States in 1900, declined to 22% in
1972, and is now at 60% for hospital-based ini-
tiation and 20% for 6 months postpartum,
with many of the latter supplementing with
formula (Figure 3) (41,42). Breast-feeding rates
are lower among lower-income populations
(41–43), but WIC educational programs
introduced in 1989–1995 markedly increased
breast-feeding in WIC participants and dra-
matically improved the national breast-feed-
ing rates because so many mothers were being
served by WIC (Figure 3) (42).
Lactation consultants in California suggest
that the low prevalence of breast-feeding
among low-income participants in the WIC
programs is linked to the dispensing of free
infant formula as well as to the belief by some
ethnic immigrant groups that infant formula
builds the larger and healthier children they see
in the United States (44). Several factors have
enabled infant formula, with $3 billion in
mass-market revenues and with powdered for-
mula in double-digit sales growth (45), to
secure a niche in the medical care system that
allows in-hospital marketing to new mothers:
Contracts with hospitals give a formula com-
pany the exclusive marketing rights to new
mothers in the hospital in exchange for free
infant formula for the hospital (44,46). Free
samples of infant formula are given to new
mothers in maternity wards in hospitals, and
breast-feeding mothers are given reduced-cost
coupons when they leave the hospital as
inducement to change (44,46). Hospitals give
infant formula to nonbreast-fed babies rather
than breast milk from archived milk banks.
Although the Baby-Friendly Hospital Initiative
aims to eliminate these practices, they are still
prevalent in many hospitals nationwide (46).
For the infant and young mother, the use
of infant formula can be just as addictive—as
difficult to reverse—as cigarette smoking.
Lactation, once ceased, cannot simply be
reinitiated, and infants, once introduced to
paciﬁers and bottle feeding, adopt the muscu-
lar sucking movements used in bottle-feeding,
which are different from those used in breast-
feeding and are difﬁcult to reverse. Habituated
soon after birth to these motions, the infant
may prefer the bottle, where flow rate is
higher and feeding impulses are satiated more
rapidly. With lower demand, the mother’s
supply of milk diminishes, and lactation spi-
rals downward until breast-feeding ceases.
Education programs can counteract the
effect of infant formula on breast-feeding.
• The community needs to know that the
breast-fed baby is a healthier baby (32);
that the POP body burdens of the commu-
nity adversely affect the health of infants
and children; that breast-feeding rescues
the infant from some of these effects
(33,34); and that breast-feeding is impor-
tant in at-risk communities with signiﬁcant
body burdens.
•M edical professionals need awareness and
training in lactation problems and their
treatment (32,46). Lactation consultants
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first, rather than the last, option recom-
mended by pediatricians when new mothers
have lactation dysfunction (44).
• Legislators need to know that proper breast-
feeding facilities (a comfortable place and
scheduled times) should be made available
at each workplace, where working, breast-
feeding mothers can collect and refrigerate
milk for their infants. Also, the United
States may take a lesson from Sweden and
Norway, where mothers have 1-year paid
maternity leave, contributing to their higher
breast-feeding rates (47).
Examples of Body-Burden
Monitoring Using Breast Milk
We have conducted community-based moni-
toring studies to measure body burdens of
POPs using breast milk as the sampling
matrix (37–39,48). These studies have estab-
lished background levels, identiﬁed hot spots,
and triggered follow-up health outcome stud-
ies (49,50). Breast milk donors are selected
according to the WHO criteria (26), and
standardized consent forms, exposure assess-
ment questionnaires, and sample collection
and storage protocols are used (37–39).
Donors are recruited from WIC Clinics or
maternal and child health clinics. 
Stockton, California. Because TCDD-
contaminated ﬁsh were reported in waterways
adjoining a superfund site in Stockton, body
burdens of TCDD were assessed in ﬁsh-eating
residents of the region (48). In collaboration
with local WIC programs, primiparae were
recruited from ethnic groups (Laotians,
Vietnamese, Cambodians, and Hmong) who
were reported to have breast-feeding rates of
25–35% and to consume signiﬁcant quantities
of local fish. However, breast-feeding preva-
lence was low (5–10%), as was consumption
of local ﬁsh. The TCDD body burdens were
also low, and this limited study (n = 40) could
find no apparent relationship between fish
consumption and TCDD levels (48). 
Kazakhstan. In an initial countrywide sur-
vey, breast milk samples were collected from
100 primiparae residing in one of seven major
population centers (37). Levels of POP body
burdens were generally similar to those found
in western Europe or the United States.
However, a hot spot of TCDD (body burdens
up to 212 pg/g lipid) was found in a cotton-
growing region in southern Kazakhstan. In
this region, body burdens of TCDD and β-
hexachlorocyclohexane averaged 10-fold
higher than levels found in European or U.S.
populations (37–39).
The unique congener pattern [TCDD
was the major (70–80%) contributor to the
toxic equivalent (TEQ) (38,39)] suggested
that the community was exposed to a
TCDD-contaminated stock of the herbicide
2,4,5-trichlorophenoxyacetic acid (2,4,5-T),
similar to the defoliant Agent Orange that
was used in Vietnam. The Soviets produced a
TCDD-contaminated 2,4,5-T defoliant
beginning in 1960. Agricultural chemicals
were heavily sprayed on cotton fields from
airplanes, and defoliants were applied two
weeks before cotton harvest. Food in the
region is home grown, and the food supply
appears widely contaminated with TCDD
(39,51). Although the TCDD levels are 10-
to 100-fold higher than U.S. levels, the TEQs
from dioxins/furans and coplanar PCBs are
only twice the U.S. levels (38). 
Conclusion
The solution to the problem of chemical
body burdens—the chemicals in our bodies,
our blood, and our breast milk—is the same
as the solution to the problem of chemicals in
our environment—our air, water, and food.
Rather than restrict our activities (breathing,
drinking, eating, or breast-feeding) or intro-
duce substitutes (bottled air or water or infant
formula), the solution is to safeguard the
health of our infants and children by control-
ling and limiting our chemical body burdens
and by encouraging breast-feeding. 
Breast milk is a valuable matrix for moni-
toring body burdens of POPs. It provides
data on background levels, hot spots, and
time trends that we need to develop policies
to limit chemical exposures. Most important,
chemical contaminants in breast milk matter
to people, and community involvement can
lead to actions that limit chemical exposures.
Breast milk is invaluable to the infant as a
source of nutrition and health, so breast-feed-
ing should be encouraged. Community-based
programs to monitor body burdens of POPs
using breast milk could be implemented in
the United States in collaboration with WIC
programs. Such programs emphasize that
increasing breast-feeding rates and decreasing
POP body burdens are both important ways
to improve the health of the infant and child. 
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